Feed Preview
Fast Growing
Human Tumor Atlas
The Human Tumor Atlas is a collaborative project that uses detailed maps of a variety of cancers to investigate cancer development, metastasis, and treatments.
Top 20 most recent papers
Biomarkers that may predict response to immunotherapy in ovarian malignancies
Current Opinion in Obstetrics & GynecologyDecember 4, 2019
Curtis D ChinJ Venkat Rao
Epigenomic dysregulation-mediated alterations of key biological pathways and tumor immune evasion are hallmarks of gingivo-buccal oral cancer
Clinical EpigeneticsDecember 3, 2019
Debodipta DasPartha P Majumder
Nanotechnology intervention of the microbiome for cancer therapy
Nature NanotechnologyDecember 1, 2019
W Kelsey SongLeaf Huang
The NanoCind® signature is an independent prognosticator of recurrence and death in uterine leiomyosarcomas
Clinical Cancer Research : an Official Journal of the American Association for Cancer ResearchDecember 3, 2019
Sabrina CroceFrédéric Chibon
A Non-interventional Clinical Trial Assessing Immune Responses After Radiofrequency Ablation of Liver Metastases From Colorectal Cancer
Frontiers in ImmunologyNovember 19, 2019
Markus W LöfflerSebastian P. Haen
The mechanism of cancer drug addiction in ALK-positive T-Cell lymphoma
OncogeneDecember 5, 2019
Soumya Sundara RajanJonathan H Schatz
Tumor propagating cells: drivers of tumor plasticity, heterogeneity, and recurrence
OncogeneDecember 4, 2019
Alexandre Teixeira VessoniLuis Francisco Zirnberger Batista
Author Correction: LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer
Scientific ReportsDecember 5, 2019
Tara BouldingSudha Narayana Rao
Mutant BRAF and MEK inhibitors regulate the tumor immune microenvironment via pyroptosis
Cancer DiscoveryDecember 3, 2019
Dan A ErkesAndrew E Aplin
The impact of systemic precision medicine and immunotherapy treatments on brain metastases
OncotargetNovember 19, 2019
Rowland H HanAlbert H. Kim
Fluorescent probes towards selective cathepsin B detection and visualization in cancer cells and patient samples
Chemical ScienceSeptember 28, 2019
Marcin PorebaGuy S Salvesen
Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65/STAT3-CSN5-PD-L1 pathway
Cell Death and DifferentiationDecember 4, 2019
Chao LiuQianming Du
Comprehensive Assessment of BARD1 Messenger Ribonucleic Acid Splicing With Implications for Variant Classification
Frontiers in GeneticsNovember 19, 2019
Logan C. WalkerMiguel de la Hoya
Extracellular vesicles of carcinoma-associated fibroblasts creates a pre-metastatic niche in the lung through activating fibroblasts
Molecular CancerDecember 3, 2019
Jing KongTingjiao Liu
Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target
OncogeneDecember 4, 2019
Panagiota S FilippouAnastasia Constantinidou
Avoidance of apoptotic death via a hyperploid salvage survival pathway after platinum treatment in high grade serous carcinoma cell line models
OncotargetNovember 19, 2019
Tony YeungAndrás Kapus
ANTI-proliferative transcriptional effects of medroxyprogesterone acetate in Estrogen receptor positive breast cancer cells are predominantly mediated by ThE progesterone receptor
The Journal of Steroid Biochemistry and Molecular BiologyDecember 2, 2019
Nicole L T MooreWayne Desmond Tilley
Resistance to BTK inhibition by ibrutinib can be overcome by preventing FOXO3a nuclear export and PI3K/AKT activation in B-cell lymphoid malignancies
Cell Death & DiseaseDecember 4, 2019
Isha KapoorAlexandru Almasan
Defining the Signature of VISTA on Myeloid Cell Chemokine Responsiveness
Frontiers in ImmunologyNovember 19, 2019
Thomas W K BroughtonJ Louise Lines
IL-17A promotes fatty acid uptake through the IL-17A/IL-17RA/p-STAT3/FABP4 axis to fuel ovarian cancer growth in an adipocyte-rich microenvironment
Cancer Immunology, Immunotherapy : CIIDecember 4, 2019
Chun-Yan YuWei-min Deng